open/close global search bar

22 July 2018 by Sanjiv Shah

Conference talk

Neladenoson bialanate in patients with chronic HFpEF (PANACHE)

About the author

profile picture of Sanjiv Shah

Sanjiv Shah

United States

Comments (0)

Related Content

Gérald Simonneau - Drug development in PAH: Where we started and where we are today thumbnail image

Conference talk

30 July 2019

{{GlobalController.truncateTitle("Gérald Simonneau - Drug development in PAH: Where we started and where we are today ", 65)}}
Olivier Sitbon - Recent Phase 2 trials in PAH that were unsuccessful thumbnail image

Conference talk

30 July 2019

{{GlobalController.truncateTitle("Olivier Sitbon - Recent Phase 2 trials in PAH that were unsuccessful", 65)}}
Kurt Stenmark - Relevance of animal models of pulmonary hypertension in drug development thumbnail image

Conference talk

30 July 2019

{{GlobalController.truncateTitle("Kurt Stenmark - Relevance of animal models of pulmonary hypertension in drug development", 65)}}
Sébestien Bonnet - Improving the rigour of preclinical studies to identify promising therapies thumbnail image

Conference talk

30 July 2019

{{GlobalController.truncateTitle("Sébestien Bonnet - Improving the rigour of preclinical studies to identify promising therapies", 65)}}
Krishna Prasad - What do regulators expect from phase 2 trials and adaptive designs? thumbnail image

Conference talk

30 July 2019

{{GlobalController.truncateTitle("Krishna Prasad - What do regulators expect from phase 2 trials and adaptive designs? ", 65)}}

Add to reading list

Please enter a list name.

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI
standard-example-image.jpg